Zobrazeno 1 - 2
of 2
pro vyhledávání: '"James Michael Pauff"'
Autor:
Lindsey Elizabeth Roeker, Alvaro Jose Alencar, Guru Subramanian Guru Murthy, Marc Steven Hoffmann, John M. Pagel, Vishalkumar Patel, James Michael Pauff, Pier Luigi Zinzani, Steven Le Gouill, Anthony Mato, Wojciech Jurczak
Publikováno v:
Journal of Clinical Oncology. 40:TPS7582-TPS7582
TPS7582 Background: B-cell lymphoma 2 (BCL2) is a key regulator of apoptosis and provides protection from cell death in many hematologic malignancies. LOXO-338 is an orally bioavailable small molecule inhibitor of BCL2, developed to achieve selectivi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::efb69c188b46004d2d29d6bb02c7ed2a
https://doi.org/10.1200/jco.2022.40.16_suppl.tps7582
https://doi.org/10.1200/jco.2022.40.16_suppl.tps7582
Autor:
Filip Janku, James J. Harding, Masafumi Ikeda, Rebecca Tupper, Matthew P. Hanley, Mary Linton B. Peters, James Michael Pauff, Carrie E. Furin, Kurt A. Jaeckle, Rachna T. Shroff, Elizabeth G. Hill, Toshio Shimizu, Lipika Goyal, James M. Cleary, Nilofer S. Azad, Anita Ahmed Turk, Xiaojian Xu, Mitesh J. Borad, Kyriakos P. Papadopoulos, Sani H. Kizilbash
Publikováno v:
Journal of Clinical Oncology. 39:TPS350-TPS350
TPS350 Background: Mutations in isocitrate dehydrogenase 1 (mIDH1) are found in approximately 20-30% of patients with intrahepatic cholangiocarcinoma (CCA), and less commonly in glioma, chondrosarcoma, and other gastrointestinal malignancies. Despite
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cb16607db9e7d9bc440e3cea8875aabb
https://doi.org/10.1200/jco.2021.39.3_suppl.tps350
https://doi.org/10.1200/jco.2021.39.3_suppl.tps350